CenterBook Partners LP Reduces Stock Holdings in Danaher Corporation $DHR

CenterBook Partners LP lessened its stake in Danaher Corporation (NYSE:DHR) by 67.6% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,026 shares of the conglomerate’s stock after selling 8,387 shares during the quarter. CenterBook Partners LP’s holdings in Danaher were worth $798,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Tyche Wealth Partners LLC acquired a new position in shares of Danaher during the third quarter worth approximately $462,000. Ceredex Value Advisors LLC raised its stake in Danaher by 1.6% during the 2nd quarter. Ceredex Value Advisors LLC now owns 249,377 shares of the conglomerate’s stock valued at $49,262,000 after acquiring an additional 3,862 shares in the last quarter. Weitz Investment Management Inc. boosted its position in Danaher by 6.1% during the 2nd quarter. Weitz Investment Management Inc. now owns 526,950 shares of the conglomerate’s stock worth $104,094,000 after acquiring an additional 30,300 shares during the period. Lockheed Martin Investment Management Co. grew its stake in shares of Danaher by 49.4% in the third quarter. Lockheed Martin Investment Management Co. now owns 25,340 shares of the conglomerate’s stock worth $5,024,000 after purchasing an additional 8,380 shares in the last quarter. Finally, Nvwm LLC increased its holdings in shares of Danaher by 20.4% during the second quarter. Nvwm LLC now owns 7,093 shares of the conglomerate’s stock valued at $1,401,000 after purchasing an additional 1,204 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Down 0.8%

DHR opened at $209.56 on Friday. The company has a market capitalization of $148.02 billion, a PE ratio of 41.58, a price-to-earnings-growth ratio of 2.83 and a beta of 0.91. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $242.80. The business has a 50-day moving average of $226.85 and a 200-day moving average of $215.89.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. The firm had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The firm’s revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.14 earnings per share. Equities research analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were issued a dividend of $0.32 per share. The ex-dividend date was Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is currently 25.40%.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on DHR shares. Robert W. Baird set a $251.00 price objective on shares of Danaher in a report on Thursday, January 29th. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Leerink Partners raised their price objective on shares of Danaher from $260.00 to $270.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. HSBC boosted their target price on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a report on Monday, December 1st. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $253.86.

Insider Activity

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the sale, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.